|
|
Product List Page 3833
|
|
Product ID |
Product Name |
CAS# |
Purity |
Y3286526 |
ß-pBrPh-Glc |
30572-42-0 |
99% |
Y3307420 |
SSR126768A |
785048-28-4 |
98% |
Y3293804 |
SOD1-Derlin-1 inhibitor-1 |
840461-03-2 |
99% |
Y3139412 |
SEL24-B489 |
1616359-00-2 |
98.58% |
Y3287100 |
KVD900 |
1933514-13-6 |
97% |
Y3139422 |
Seliforant |
1164115-89-2 |
95.0% |
Y3305551 |
RDR03871 |
286008-51-3 |
97% |
Y3304595 |
Rapastinel acetate |
491872-39-0 |
99% |
Y3316753 |
PSEUDOMONIC ACID D |
85248-93-7 |
95% |
Y3292144 |
PS121912 |
1529814-60-5 |
95% |
Y3139428 |
PR-104A |
680199-06-8 |
98% |
Y3290243 |
PFM39 |
1310744-67-2 |
98% |
Y3304805 |
PF-00217830 |
846032-02-8 |
98% |
Y3293419 |
Paltusotine |
2172870-89-0 |
99% |
Y3306130 |
Ocedurenone |
1359969-24-6 |
98% |
Y3144709 |
NTRC 0066-0 |
1817791-73-3 |
99% |
Y3293096 |
NSC668394 |
382605-72-3 |
99% |
Y3144397 |
NP-1815-PX sodium |
1239578-80-3 |
99% |
Y3288045 |
Zandatrigine |
2154406-04-7 |
99% |
Y3144398 |
MK-6884 |
2102194-04-5 |
99% |
Y3144399 |
Modoflaner |
1331922-53-2 |
98.01% |
Y3310589 |
MK-8325 |
1334314-19-0 |
100% |
Y3312739 |
Minesapride |
1184662-54-1 |
100% |
Y3288089 |
MD-222 |
2136246-72-3 |
99% |
Y3308475 |
MB-07729 |
882755-95-5 |
99% |
Y3305342 |
M7594_0037 |
774551-07-4 |
97% |
Y3292696 |
M1002 |
823830-85-9 |
99% |
Y3144404 |
JUN-1111 |
874351-38-9 |
98% |
Y3308164 |
JNJ-42253432 |
1428327-35-8 |
99% |
Y3309907 |
JI130 |
2234271-86-2 |
99% |
Y3298015 |
Ivospemin |
748119-79-1 |
99% |
Y3310689 |
Impromidine hydrochloride |
65573-02-6 |
99% |
Y3308806 |
inS3-54-A26 |
328998-77-2 |
98% |
Y3103415 |
N-(3-(5-Chloro-2-(difluoromethoxy)phenyl)-1-(2-(4-((2-cyanoethyl)(methyl)amino)piperidin-1-yl)-2-oxoethyl)-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide |
1831144-46-7 |
97% |
Y3291129 |
Ifetroban sodium |
156715-37-6 |
99% |
Y3137175 |
Ibiglustat succinate |
1629063-80-4 |
99% |
Y3287329 |
I942 |
868145-09-9 |
99% |
Y3137208 |
HSD-016 |
946396-92-5 |
99% |
Y3311332 |
HXJ42 |
1428640-39-4 |
99% |
Y3310984 |
H3B-8800 |
1825302-42-8 |
98% |
Y3309472 |
GSK2647544 |
1380426-95-8 |
99% |
Y3309872 |
FT001 |
1778655-51-8 |
100% |
Y3289865 |
GAC0001E5 |
927969-67-3 |
95% |
Y3137158 |
Fosgonimeton |
2093305-05-4 |
99.61% |
Y3288120 |
PI3Kd/-IN-1 |
1980884-01-2 |
99% |
Y3137173 |
Fluoroethylnormemantine |
1639210-26-6 |
98% |
Y3295779 |
FC-11 |
2271035-37-9 |
99% |
Y3130521 |
Epitinib succinate |
2252334-12-4 |
99.01% |
Y3316862 |
DN401 |
2135749-60-7 |
100% |
Y3287705 |
Deuruxolitinib-d8 |
1513883-39-0 |
99% |
Y3308860 |
DDD100097 |
1215012-74-0 |
99% |
Y3310302 |
DCZ3301 |
2136278-38-9 |
99% |
Y3292448 |
dBET23 |
1957234-83-1 |
99% |
Y3308818 |
Crobenetine |
221019-25-6 |
98% |
Y3287723 |
Contezolid acefosamil sodium |
1807365-35-0 |
99% |
Y3294752 |
CP26 |
500285-30-3 |
98% |
Y3316344 |
Benzene, 5-[2-(3,4-dimethoxyphenyl)ethyl]-1,2,3-trimethoxy- |
108853-09-4 |
98% |
Y3311551 |
Chst15-IN-1 |
2158198-77-5 |
98% |
Y3309572 |
CG 428 |
2412055-93-5 |
98% |
Y3307035 |
Cdc7 inhibitor 7c |
1330781-04-8 |
99% |
Y3131944 |
CC-90005 |
1799574-70-1 |
99.98% |
Y3288332 |
Cantrixil |
2135511-22-5 |
99% |
Y3286938 |
CAD031 |
2071209-49-7 |
99% |
Y3297056 |
Cyclotriazadisulfonamide |
182316-44-5 |
98% |
Y3294508 |
Budiodarone tartrate |
478941-93-4 |
99% |
Y3297256 |
BMS-37 |
1675202-20-6 |
98% |
Y3291251 |
BMS-817399 |
1202400-18-7 |
99% |
Y3289896 |
Befotertinib |
1835667-63-4 |
99% |
Y3305254 |
Avasopasem manganese |
435327-40-5 |
96% |
Y3131792 |
ASP-4058 hydrochloride |
952510-14-4 |
99% |
Y3294777 |
ARD-61 |
2316837-08-6 |
99% |
Y3292432 |
ARD-69 |
2316837-10-0 |
99% |
Y3306665 |
AGN-201904 |
651729-53-2 |
97% |
Y3292113 |
AJS1669 free acid |
1853130-05-8 |
99% |
Y3307783 |
AA-CW236 |
1869921-96-9 |
99% |
Y3289120 |
ABT-510 acetate |
442526-87-6 |
99% |
Y3308017 |
EPAC 5376753 |
302826-61-5 |
95% |
Y3286433 |
N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfanyl]propanamide |
1477919-27-9 |
98% |
Y3295245 |
P-gp inhibitor 1 |
2050747-49-2 |
98% |
Y3297306 |
Hsp90-Cdc37-IN-1 |
2227303-22-0 |
99% |
Y3131801 |
ZEN-3219 |
1952264-34-4 |
99% |
Y3307220 |
RIP2 Kinase Inhibitor 3 |
1398053-50-3 |
98% |
Y3314926 |
5,5-Dimethyl-3-(2-((7-methyl-2H-spiro[benzofuran-3,1'-cyclopropan]-4-yl)oxy)pyrimidin-5-yl)imidazolidine-2,4-dione |
1380696-64-9 |
99% |
Y3131798 |
CKD-519 |
1402796-27-3 |
99% |
Y3310332 |
RORt Inverse agonist 3 |
2364429-77-4 |
99.93% |
Y3311956 |
CHMFL-KIT-033 |
2351801-41-5 |
97% |
Y3304956 |
PD-1-IN-22 |
2349372-98-9 |
98% |
Y3131821 |
GPR35 agonist 1 |
2079880-92-3 |
99% |
Y3131814 |
MPT0B392 |
1346169-92-3 |
99% |
Y3305546 |
Chalcone 4 hydrate |
1202866-96-3 |
98% |
Y3288084 |
Tubulysin |
1943604-24-7 |
99% |
Y3305695 |
Antitumor agent-19 |
2379727-90-7 |
98% |
Y3131826 |
BTL-104 |
753451-66-0 |
99% |
Y3295574 |
RH01386 |
301177-36-6 |
99% |
Y3102966 |
Troriluzole |
1926203-09-9 |
98% |
Y3131815 |
BPI-9016M |
1528546-94-2 |
97% |
Y3312554 |
RAS GTPase inhibitor 1 |
2252242-32-1 |
99% |
Y3131825 |
JH-LPH-33 |
2414590-04-6 |
98% |
Y3131831 |
CB2 modulator 1 |
666261-80-9 |
99% |
Y3313472 |
Syk-IN-3 |
1312534-69-2 |
96% |
|
|
|
|
|
|